Form 4: Hologic Director Amy Wendell Acquires 3,190 Shares

Hologic Inc. Director Amy Wendell reported the acquisition of 3,190 restricted stock units, increasing her direct beneficial ownership to 25,784 shares.

Summary

• Amy McBride Wendell, a Director of Hologic Inc. (HOLX), acquired 3,190 shares of common stock.
• The transaction occurred on February 26, 2026, and was an acquisition (Code 'A').
• These acquired shares represent restricted stock units (RSUs) that will vest on the date of the 2027 Annual Meeting of Stockholders.
• The RSUs are settled in shares of common stock on a one-for-one basis.
• Following this transaction, Ms. Wendell's direct beneficial ownership of Hologic Inc. common stock increased to 25,784 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event. While a routine compensation grant, it signifies a director's increased stake in the company, aligning their financial interests with long-term shareholder value.

Positives

• The acquisition of restricted stock units by a director aligns management's interests with those of shareholders, potentially signaling confidence in the company's future performance.

Future Outlook

The acquired restricted stock units are scheduled to vest on the date of the 2027 Annual Meeting of Stockholders, indicating a future alignment of the director's compensation with long-term company performance.

Industry Context

StockSavvy.ai notes that insider acquisitions, even through routine restricted stock unit grants, are a common mechanism to align the interests of corporate directors with those of shareholders. This practice is consistent across many industries, aiming to incentivize long-term value creation.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director through RSUs can be seen as a positive signal, as it further aligns the director's financial incentives with the company's long-term performance and shareholder returns.

Next Steps

• The restricted stock units are expected to vest on the date of the 2027 Annual Meeting of Stockholders.

Key Dates

Recommendation

This filing reports a routine grant of restricted stock units to a director, which is a common form of compensation and aligns the director's interests with shareholders. It does not present new information that would significantly alter the company's fundamental outlook or warrant a strong buy or sell recommendation at this time.

Keywords

Hologic Inc., HOLX, Amy Wendell, Director, Restricted Stock Units, RSU, Insider Transaction, Beneficial Ownership, Corporate Governance